• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在冠状病毒病（COVID-19）中的作用：多数情况下促进康复，有时也会造成损害。
Respirology. 2020 Jul;25(7):680-682. doi: 10.1111/resp.13852. Epub 2020 May 20.
2
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
3
Going back in time for an antibody to fight COVID-19.回溯过去寻找对抗新冠病毒的抗体。
Nature. 2020 Jul;583(7815):203-204. doi: 10.1038/d41586-020-01816-5.
4
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠患者体内抗新冠病毒抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1694-1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
5
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.轻度新冠肺炎中抗SARS-CoV-2抗体的丧失。回复。
N Engl J Med. 2020 Oct 22;383(17):1697-1698. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
6
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.新型冠状病毒肺炎患者中抗严重急性呼吸综合征冠状病毒2 IgM和IgG抗体的动态变化
J Infect. 2020 Aug;81(2):e55-e58. doi: 10.1016/j.jinf.2020.04.019. Epub 2020 Apr 23.
7
Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2?寻找骆驼-OT：抗击 SARS-CoV-2 大流行的圣杯？
Sci Immunol. 2020 Jul 3;5(49). doi: 10.1126/sciimmunol.abd4758.
8
SARS-CoV-2: virus dynamics and host response.严重急性呼吸综合征冠状病毒2：病毒动力学与宿主反应
Lancet Infect Dis. 2020 May;20(5):515-516. doi: 10.1016/S1473-3099(20)30235-8. Epub 2020 Mar 23.
9
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻症新冠患者体内抗SARS-CoV-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
10
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠病毒感染中抗新冠病毒-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695-1696. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.

引用本文的文献

1
A multicentre study comparing post-mortem SARS-CoV-2 antibody testing in Cape Town mortuaries.一项比较开普敦各太平间尸检中SARS-CoV-2抗体检测情况的多中心研究。
S Afr J Infect Dis. 2025 Mar 31;40(1):683. doi: 10.4102/sajid.v40i1.683. eCollection 2025.
2
Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.泰国有症状和无症状的新冠病毒感染者的抗体反应。
PLoS One. 2025 Feb 11;20(2):e0308850. doi: 10.1371/journal.pone.0308850. eCollection 2025.
3
Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers.在养老院居民和医护人员中，BNT162b2 mRNA 疫苗初级和加强剂量后的体液免疫应答的亲和成熟度。
Geroscience. 2024 Dec;46(6):6183-6194. doi: 10.1007/s11357-024-01215-y. Epub 2024 May 25.
4
A new multiplex SARS-CoV-2 antigen microarray showed correlation of IgG, IgA, and IgM antibodies from patients with COVID-19 disease severity and maintenance of relative IgA and IgM antigen binding over time.一种新的多重 SARS-CoV-2 抗原微阵列显示，COVID-19 疾病严重程度与患者的 IgG、IgA 和 IgM 抗体之间存在相关性，并且相对 IgA 和 IgM 抗原结合随时间推移而保持。
PLoS One. 2023 Mar 30;18(3):e0283537. doi: 10.1371/journal.pone.0283537. eCollection 2023.
5
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes.重症 COVID-19 患者及死亡病例的中和抗体和总抗体反应的纵向特征分析
Vaccines (Basel). 2022 Dec 1;10(12):2063. doi: 10.3390/vaccines10122063.
6
Antibody Dependent Enhancement of SARS-CoV-2 Infection in the Era of Rapid Vaccine Development.抗体依赖性增强作用促进 SARS-CoV-2 感染：在疫苗快速开发时代。
Med Arch. 2022 Oct;76(5):383-386. doi: 10.5455/medarh.2022.76.383-386.
7
COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity.COVID-19 患者表现出独特的转录特征，表明疾病的严重程度。
Front Immunol. 2022 Sep 15;13:989556. doi: 10.3389/fimmu.2022.989556. eCollection 2022.
8
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.严重急性呼吸综合征冠状病毒 2 重组 S 蛋白、受体结合域及其受体结合基序在 COVID-19 患者中的血清学反应及其与疟疾流行地区 COVID-19 前样本的交叉反应性。
Front Immunol. 2022 Apr 27;13:856033. doi: 10.3389/fimmu.2022.856033. eCollection 2022.
9
Dynamics of viral RNA load, virus culture, seroconversion & infectivity in COVID-19 patients: Implications on isolation policy.新型冠状病毒感染患者的病毒 RNA 载量、病毒培养、血清转化和传染性动力学：对隔离政策的影响。
Indian J Med Res. 2021;153(5&6):585-590. doi: 10.4103/ijmr.IJMR_3564_20.
10
Clinical relevance of SARS-CoV-2 infection in late pregnancy.SARS-CoV-2 感染在妊娠晚期的临床相关性。
BMC Pregnancy Childbirth. 2021 Jul 12;21(1):505. doi: 10.1186/s12884-021-03985-1.

本文引用的文献

1
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫球蛋白G和IgM抗体概况
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.
2
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
3
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
4
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
5
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征：一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
6
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).分析早期体液免疫反应以诊断新型冠状病毒病（COVID-19）。
Clin Infect Dis. 2020 Jul 28;71(15):778-785. doi: 10.1093/cid/ciaa310.
7
Compromised steady-state germinal center activity with age in nonhuman primates.非人类灵长类动物中随年龄增长而导致的生发中心稳态活性受损。
Aging Cell. 2020 Feb;19(2):e13087. doi: 10.1111/acel.13087. Epub 2019 Dec 15.
8
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.抗刺突 IgG 通过在急性 SARS-CoV 感染期间使巨噬细胞反应发生偏斜，导致严重的急性肺损伤。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.123158.
9
Immunoglobulin G glycosylation in aging and diseases.免疫球蛋白 G 的糖基化在衰老和疾病中的作用。
Cell Immunol. 2018 Nov;333:65-79. doi: 10.1016/j.cellimm.2018.07.009. Epub 2018 Jul 23.
10
Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.1型人类免疫缺陷病毒（HIV-1）特异性IgG抗体的抗病毒功能：抗逆转录病毒疗法的影响及对治疗性HIV-1疫苗设计的启示
Front Immunol. 2017 Jul 4;8:780. doi: 10.3389/fimmu.2017.00780. eCollection 2017.

The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.

作者信息

French Martyn A, Moodley Yuben

机构信息

School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.

Division of Immunology, PathWest Laboratory Medicine, Perth, WA, Australia.

出版信息

Respirology. 2020 Jul;25(7):680-682. doi: 10.1111/resp.13852. Epub 2020 May 20.

DOI:10.1111/resp.13852
PMID:32436320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7280731/
Abstract
摘要